Since the application of the new criteria on endocrine disruptor (ED) in the scope of the Biocidal Product Regulation (BPR- Reg 528/2012), the pressure is put on the ED-evaluation of the active substance and the co-formulants of the biocidal products. This situation...
This site uses cookies to improve your user experience. I acknowledge that I have read the privacy policy applicable on this site.
